Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375070
Status:
COMPLETED
Last Update Posted:
2024-04-19
First Post:
2024-04-16
Brief Title:
Anticoagulants for PFO Patients
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients who underwent both bubble transcranial Doppler bubble-TCD and transoesophageal echocardiography TEE at our institution were consecutively enrolled in this real-world case-control study from August 2016 through August 2023 The patients were categorized into three groups based on the degree of the shunt observed mild 3-9 bubbles moderate 10-30bubbles and severe more than 30 bubbles In cases with mild-shunt small-size PFO post-procedural anticoagulation or PFO closure was administered Subsequent to the interventions the follow-up encompassed the recording of migraine remission recurrent neurological incidents instances of major bleeding and mortality
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None